中国医学创新Issue(12)：132-133,2.DOI:10.3969/j.issn.1674-4985.2013.12.069
巴曲酶联合依达拉奉治疗急性脑梗死的临床观察
Observation on Effect of Batroxobin in Combined with Edaravone to Treat Acute Cerebral Infarction Patients
李劲松 1刘雨红 1刘玉坤1
作者信息
- 1. 辽宁省葫芦岛市连山区人民医院 辽宁 葫芦岛 125001
- 折叠
摘要
Abstract
Objective:To observe the effect of batroxobin enzymes with edaravone for treatment of acute cerebral infarction. Method:To retrospectively analyze 45 cases who with acute cerebral infarction had lost thrombolysis opportunities. Result:The total efficiency and markedly effective rate of the combined group was significantly better than that of batroxobin group(P<0.05). Combination therapy did not affect the batroxobin defibrase role. Compared the two groups of neurological deficit scores before and after treatment,there were significantly lower(P<0.01). The combined group improved more significantly than batroxobin group(P<0.01). The incidences of adverse reactions of the two groups were few and mild. Conclusion:Batroxobin edaravone method can be effective in treating acute cerebral infarction,and significantly improve the patient’s neurological deficit.关键词
巴曲酶/依达拉奉/急性脑梗死Key words
Batroxobin/Edaravone/Acute cerebral infarction引用本文复制引用
李劲松,刘雨红,刘玉坤..巴曲酶联合依达拉奉治疗急性脑梗死的临床观察[J].中国医学创新,2013,(12):132-133,2.
